Back to Journals » Vascular Health and Risk Management » Volume 12

Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders

Total article views   Abstract views HTML views PDF downloads Totals
9,189 Dovepress* 4,652 3,320+ 1,345 7,972
PubMed Central* 0 1,217 467 1,217
Totals 4,652 4,537 1,812 9,189
*Since 10 November 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar